ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Virtual Booth

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

1PROSPECTS

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

API/FDF Prices: Book a Demo

API REF. PRICE (USD/KG)

$ 0

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Regulatory FDF Prices

MARKET PLACE

API

FDF

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 2436472-47-6, Arn-75039, H42w39d3bm, Chembl4871246, Schembl22071837, Ex-a7382

Molecular Formula

C₂₇H₃₀N₂O₂

Molecular Weight

414.5 g/mol

InChI Key

TWUXCBSMDFLDBC-UHFFFAOYSA-N

FDA UNII

H42W39D3BM

1 2D Structure

ARN-75039

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

7-methyl-3-[4-[(2-methylpropan-2-yl)oxy]phenyl]-6-(4-propan-2-yloxyphenyl)imidazo[1,2-a]pyridine

2.1.2 InChI

InChI=1S/C27H30N2O2/c1-18(2)30-22-11-7-20(8-12-22)24-17-29-25(16-28-26(29)15-19(24)3)21-9-13-23(14-10-21)31-27(4,5)6/h7-18H,1-6H3

2.1.3 InChI Key

TWUXCBSMDFLDBC-UHFFFAOYSA-N

2.2 Other Identifiers

2.2.1 UNII

H42W39D3BM

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. 2436472-47-6

2. Arn-75039

3. H42w39d3bm

4. Chembl4871246

5. Schembl22071837

6. Ex-a7382

7. Db-393772

8. 3-(4-(tert-butoxy)phenyl)-6-(4-isopropoxyphenyl)-7-methylimidazo[1,2-a]pyridine

9. 3-[4-(1,1-dimethylethoxy)phenyl]-7-methyl-6-[4-(1-methylethoxy)phenyl]imidazo[1,2-a]pyridine

10. Imidazo[1,2-a]pyridine, 3-[4-(1,1-dimethylethoxy)phenyl]-7-methyl-6-[4-(1-methylethoxy)phenyl]-

2.4 Create Date

2020-06-27

3 Chemical and Physical Properties

Molecular Formula	C₂₇H₃₀N₂O₂
Molecular Weight	414.5 g/mol
XLogP3	7.1
Hydrogen Bond Donor Count	0
Hydrogen Bond Acceptor Count	3
Rotatable Bond Count	6
Exact Mass	Da
Monoisotopic Mass	Da
Topological Polar Surface Area	35.8
Heavy Atom Count	31
Formal Charge	0
Complexity	558
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

Drugs in Development

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Find ARN-75039 manufacturers, exporters & distributors on PharmaCompass

ARN-75039

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

DEVELOPMENTS

3 Drugs in Development

ACTIVE PHARMA INGREDIENTS

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

FINISHED DOSAGE FORMULATIONS

1PROSPECTS

3DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

API REF. PRICE (USD/KG)

$ 0

GLOBAL SALES INFORMATION

MARKET PLACE

DIGITAL CONTENT

What are you looking for?